ArticleScientific reports2017

Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study.

Caroline Sindet-Pedersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.